Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia (Q24187178)

Europe PubMed Central

title

Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia (English)

0 references

author name string

Kasra Moazzami

1

0 references

Bobak Moazzami

2

0 references

Aria Roohi

3

0 references

Saharnaz Nedjat

4

0 references

Elena Dolmatova

Cochrane Database of Systematic Reviews

5

0 references

publication date

19 December 2014

0 references

published in

0 references

cites work

Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Transplantation of purified CD34+ cells in the treatment of critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine(2A) antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Treatment of non-healing skin ulcers with autologous activated mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Autologous bone marrow mononuclear cells transplant in patients with critical leg ischemia: preliminary clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease-results of the short- and long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Augmentation of postnatal neovascularization with autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB3

Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Controlled-release basic fibroblast growth factor for peripheral artery disease: comparison with autologous bone marrow-derived stem cell transfer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Megadoses of autologous Tissue Repair Cells (TRC) in the treatment of Ischemia induced chronic issue ulcers of diabetic foot patients without option of revascularisation ? preliminary results from Bad Oeynhausen

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

Effective autologous bone marrow stem cell dosage for treatment of severe lower limb ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25525690

12 December 2020

10.1002/14651858.CD008347.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

25525690

1 reference

Consolidated OpenCitations Corpus – April 2017